Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | UGT1A1 | P22309 | 2/20 | 1.00 |
| ▸ | UGT1A8 | Q9HAW9 | 1/20 | 1.00 |
| ▸ | MAPT | P10636 | 10/20 | 0.56 |
| ▸ | TP53 | P04637 | 8/20 | 0.56 |
| ▸ | CYP3A4 | P08684 | 8/20 | 0.56 |
| ▸ | HPGD | P15428 | 8/20 | 0.56 |
| ▸ | MEN1 | O00255 | 8/20 | 0.56 |
| ▸ | KMT2A | Q03164 | 8/20 | 0.56 |
| ▸ | SMN1; SMN2 | Q16637 | 8/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.56 |
| ▸ | NPC1 | O15118 | 6/20 | 0.56 |
| ▸ | RAB9A | P51151 | 6/20 | 0.56 |
| ▸ | ALOX15 | P16050 | 5/20 | 0.56 |
| ▸ | MAPK1 | P28482 | 4/20 | 0.56 |
| ▸ | CYP2C9 | P11712 | 4/20 | 0.56 |
| ▸ | CYP2C19 | P33261 | 4/20 | 0.56 |
| ▸ | TSHR | P16473 | 3/20 | 0.56 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.56 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.56 |
| ▸ | ESR1 | P03372 | 3/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Irisolone SCHEMBL242540 | 0.85 | UGT1A1 (0.73) | UGT1A1UGT1A8MAPTTP53CYP3A4 | |
| Irisolone SCHEMBL29928854 | 0.85 | UGT1A1 (0.73) | UGT1A1UGT1A8MAPTTP53CYP3A4 | |
| SCHEMBL29441847 | 0.83 | UGT1A1 (0.71) | UGT1A1UGT1A8MAPTTP53CYP3A4 | |
| SCHEMBL29696493 | 0.82 | UGT1A1 (0.69) | UGT1A1UGT1A8MAPTTP53CYP3A4 | |
| SCHEMBL7760763 | 0.79 | PPARG (0.70) | UGT1A1UGT1A8MAPTTP53CYP3A4 | |
| SCHEMBL6412437 | 0.79 | UGT1A1 (0.65) | UGT1A1UGT1A8MAPTTP53CYP3A4 | |
| Irisone A SCHEMBL571686 | 0.78 | UGT1A1 (0.64) | UGT1A1UGT1A8MAPTTP53CYP3A4 | |
| SCHEMBL13279932 | 0.77 | MAPT (0.75) | UGT1A1UGT1A8MAPTTP53CYP3A4 | |
| SCHEMBL30525493 | 0.77 | MAPT (0.75) | UGT1A1UGT1A8MAPTTP53CYP3A4 | |
| SCHEMBL17718213 | 0.74 | EGFR (0.63) | UGT1A1UGT1A8MAPTTP53CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 69 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250051551-A1 | IMPROVED POLYMER COMPOSITES | WARNER BABCOCK INSTITUTE FOR GREEN CHEMISTRY, LLC (US) | 2025-02-13 | — | — | US | claimed |
| US-20250009655-A1 | BIPHASIC COMPOSITIONS COMPRISING ONE OR BOTH OF CARBONATE AND PHOSPHATE | Natural Extraction Systems, LLC | 2025-01-09 | — | — | US | claimed |
| US-20240315965-A1 | COMPOSITIONS AND METHODS RELATED TO PHARMACEUTICAL EXCIPIENTS | Natural Extraction Systems, LLC (US) | 2024-09-26 | — | — | US | claimed |
| WO-2023150072-A1 | COMPOSITIONS AND METHODS FOR THE PRESERVATION OF PLANT MATTER | SINCLAIR DAVID A (US) | 2023-08-10 | — | — | WO | claimed |
| WO-2023064318-A1 | BIPHASIC COMPOSITIONS COMPRISING ONE OR BOTH OF CARBONATE AND PHOSPHATE | Natural Extraction Systems, LLC (US) | 2023-04-20 | — | — | WO | claimed |
| CN-115957232-A | Anti-aging, anti-glycosylation, antioxidant and anti-inflammatory cell nano-product and preparation method and application thereof | 广州辛选供应链有限公司 | 2023-04-14 | — | — | CN | claimed |
| US-20230089351-A1 | METHODS RELATED TO BIOACTIVE AGENTS THAT CONVERT FROM ANIONS TO MOLECULES | Natural Extraction Systems, LLC (US) | 2023-03-23 | — | — | US | claimed |
| CN-115429821-A | Compound probiotic composition for preventing dental caries and regulating intestinal flora and immunity and preparation method and application thereof | 北京科拓恒通生物技术股份有限公司 | 2022-12-06 | — | — | CN | claimed |
| WO-2022182523-A1 | COMPOSITIONS RELATED TO BIOACTIVE AGENTS THAT CONVERT FROM ANIONS TO MOLECULES | Natural Extraction Systems, LLC (US) | 2022-09-01 | — | — | WO | claimed |
| WO-2022182527-A1 | COMPOSITIONS AND METHODS RELATED TO PHARMACEUTICAL EXCIPIENTS | Natural Extraction Systems, LLC (US) | 2022-09-01 | — | — | WO | claimed |
| CN-114796236-A | Composition for treating dementia | 史蒂文·霍夫曼 | 2022-07-29 | — | — | CN | claimed |
| CN-114306183-A | Novel use of plant-derived alkaline phosphatase expression promoter | 香港科技大学 | 2022-04-12 | — | — | CN | claimed |
| CN-114272346-A | Foot health product for treating rheumatoid arthritis | 苏州大学 | 2022-04-05 | — | — | CN | claimed |
| EP-4190172-B1 | SWEETENER COMPOSITION COMPRISING STEVIOL GLYCOSIDE SWEETENERS WITH IMPROVED FLAVOR PROFILES | COCA COLA CO (US) | 2025-11-26 | — | — | EP | disclosed |
| US-12390418-B2 | Biphasic compositions comprising one or both of carbonate and phosphate | Natural Extraction Systems, LLC (US) | 2025-08-19 | — | — | US | disclosed |
| US-20250161394-A1 | Compositions Comprising Kavalactones | NATURAL EXTRACTION SYS LLC (US) | 2025-05-22 | — | — | US | disclosed |
| CN-113274475-B | Traditional Chinese medicine for treating rheumatoid arthritis | 苏州大学 | 2022-02-22 | — | — | CN | disclosed |
| WO-2011163241-A2 | NEUROPROTECTIVE COMPOUNDS | GEORGETOWN UNIVERSITY (US) | 2011-12-29 | — | — | WO | disclosed |
| CN-100569241-C | Celery seed acetic acid ethyl ester extract and uses thereof | BEIJING TIANCHUN JUNWEI MEDICI (CN) | 2009-12-16 | — | — | CN | disclosed |
| CN-101007015-A | Application of flavonoids of celery seed and coumarins in preparation of drug for preventing and treating gout | BEIJING TIANCHUN JUNWEI MEDICI (CN) | 2007-08-01 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230089351-A1 | METHODS RELATED TO BIOACTIVE AGENTS THAT CONVERT FROM ANIONS TO MOLECULES | FABP2, FABP4, GUSB | UGT1A1 1445/4885UGT1A8 1189/4885MAPT 3926/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.